Reassessment of estrogen receptor expression in human breast cancer cell lines

Anticancer Research

Volumn 31, Issue 2, 2011, Pages 521-527

  Ford, Christopher H J ^a   Maie, A L Bader ^a   Bushra, A L Ayadhi ^a   Issam, Francis ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Breast cancer cell lines; Estrogen receptor; Flow cytometry; RT PCR; Western blotting

Indexed keywords

ANTIESTROGEN; CYTOPLASMIC RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PERMEABILIZATION; FLOW CYTOMETRY; HORMONE DETERMINATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; DOWN-REGULATION; ESTROGEN RECEPTOR ALPHA; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79953235933     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Clemons M and Goss P: Estrogen and the risk of breast cancer. New Eng J Med 344: 276-285, 2001. (Pubitemid 32108534)
2. Greene GL, Closs LE, Flemming H, DeSombre ER and Jensen EV: Antibodies to estrogen receptor: immunochemical similarity of estrophilin from various mammalian species. Proc Nat Acad Sci USA 74: 3681-3685, 1977. (Pubitemid 8189946)
3. Mosselman S, Polman J and Dijkema R: ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett 392: 49-53, 1996.
4. Jensen EV and Jordan VC: The estrogen receptor: a model for molecular medicine. Clin Cancer Res 9: 1980-1989, 2003.
5. Ellmann S, Sticht H, Thiel F, Beckmann MW, Strick R and Strissel PL: Estrogen and progesterone receptors: from molecular structures to clinical targets. Cell Mol Life Sci 66: 2405-2426, 2009.
6. Lacroix M and Leclercq G: Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 83: 249-289, 2004. (Pubitemid 38264873)
7. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, Wang Q, Bekiranov S, Sementchenko V, Fox EA, Silver PA, Gingeras TR, Liu XS and Brown M: Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38: 1289-1297, 2006. (Pubitemid 44646291)
8. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe J-P, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo W-L, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A and Gray JW: A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515-527, 2006. (Pubitemid 44854747)
9. Swedenborg E, Power KA, Cai W, Pongratz I and Ruegg J: Regulation of estrogen receptor beta activity and implications in health and disease. Cell Mol Life Sci 66: 3873-3894, 2009.
10. Levin ER: Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrin 19: 1951-1959, 2005.
11. Sabe I, Andritsch I, Mangoud A, Awad AS, Khalifa A and Krishnan A: Flow cytometric analysis of estrogen receptor expression in islolated nuclei and cells from mammary cancer tissues. Cytometry 36: 131-139, 1999. (Pubitemid 29247126)
12. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987. (Pubitemid 17064313)
13. Al-Bader MD: Estrogen receptor alpha and beta in rat placenta: detection by RT-PCR, real-time PCR and Western blotting. Reprod Biol Endocrinol 4: 13-22, 2006.
14. Zhang Q-X, Hilsenbeck SG, Fuqua AW and Borg,A: Multiple splicing variants of the estrogen receptor are present in individual human breast tumors. J Steroid Biochem Mol Biol 59: 251-260, 1996. (Pubitemid 27037931)
15. Leygue E, Dotzlaw H, Watson PH and Murphy LC: Expression of estrogen receptor β1, β2, and β5 messenger RNAs in human breast tissue. Cancer Res 59: 1175-1179, 1999.
16. Allred DG, Harvey JM, Berardo M and Clark GM: Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11: 155-168, 1998. (Pubitemid 28144151)
17. Diaz LK and Sneige N: Estrogen receptor analysis for breast cancer. Adv Anat Pathol 12: 10-19, 2005.
18. Redkar A and Krishan A: Flow cytometric analysis of estrogen, progesterone receptor expression and DNA content in formalin-fixed, paraffin-embedded human breast tumors. Cytometry (Comm Clin Cytometry) 38: 61-69, 1999. (Pubitemid 29203245)
19. Leers MPG, Schutte B, Theunissen PHMH, Ramaekers FCS and Nap M: A novel flow cytometric steroid hormone receptor assay for paraffin-embedded breast carcinomas: an objective quantification of the steroid hormone receptors and direct correlation to ploidy status and proliferative capacity in a single-tube assay. Hum Pathol 31: 584-592, 2000. (Pubitemid 30323984)
20. Cao S, Hudnall SD, Kohen F and Lu L-J W: Measurement of estrogen receptors in intact cells by flow cytometry. Cytometry 41: 109-114, 2000.
21. Girdler F, Browell DA, Cunliffe WJ, Shenton BK, Hemming JD, Scorer P, Young JR and Brotherick I: Use of monoclonal antibody DAKO-ERβ (8D5-1) to measure oestrogen receptor beta in breast cancer cells. Cytometry 45: 65-72, 2001.
22. Gritzapis AD, Baxevanis CN, Missitzis I, Katsanou ES, Alexis MN, Yotis J and Papamichail M: Quantitative fluorescence cytometric measurement of estrogen and progesterone receptors: correlation with the hormone binding assay. Breast Cancer Res Treat 80: 1-13, 2003. (Pubitemid 36851280)
23. De-Ding T, Min J, Jian-Hong W, Yong-Dong F and Jian-Ping G: Western blot analysis and flow cytometric analysis of estrogen and progesterone receptors in fixed breast cancer cells. Chin J Cancer 23: 339-341, 2004.
24. Lacroix M: Persistent use of 'false' cell lines. Int J Cancer 122: 1-4, 2008.
25. Rae JM, Creighton CJ, Meck JM, Haddad BR and Johnson MD: MDA-MB435 cells are derived from M14 melanoma cells - a loss for breast cancer, but a boom for melanoma research. Breast Cancer Res Treat 104: 13-19, 2007. (Pubitemid 46976633)
26. Hughes P, Marshall D, Reid Y, Parkes H and Gelber C: The costs of using unauthenticated, over-passaged cell lines: How much more data do we need? BioTechniques 43: 575-586, 2007.
27. Simoncini T and Genazzani AR: Non-genomic actions of sex steroid hormones. Eur J Endocrin 148: 281-292, 2003. (Pubitemid 36410713)
28. Manavathi B and Kumar R: Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin. J Cell Physiol 207: 594-604, 2006. (Pubitemid 43670418)
29. Powell C, Soto A and Sonnenschein C: Identification and characterization of membrane estrogen receptor from MCF7 estrogen-target cells. J Steroid Biochem Mol Biol 77: 97-108, 2001. (Pubitemid 32476817)
30. Zivadinovic D, Gametchu B and Watson CS: Membrane estrogen receptor-α levels in MCF-7 breast cancer cells predict cAMP and proliferation responses. Breast Cancer Res 7: R101-R112, 2004.
31. Norfleet AM, Thomas ML, Gametchu B and Watson CS: Estrogen receptor-α detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry. Endocrinology 140: 3805-3814, 1999. (Pubitemid 30645438)
32. Campbell CH, Bulayeva N, Brown DB, Gametchu B and Watson CS: Regulation of the membrane estrogen receptor-α: role of cell density, serum, cell passage number, and estradiol. FASEB J 16: 1717-1927, 2002.
33. Patrone C, Anderson S, Korhonen L and Lindholm D: Estrogen receptor-dependent regulation of sensory neuron survival in developing dorsal root ganglion. PNAS 96: 10905-10910, 1999. (Pubitemid 29442242)
34. Vladusic EA, Hornby AE, Guerra-Vladusic FK, Lakins J and Lupu R: Expression and regulation of estrogen receptor β in human breast tumors and cell lines. Oncol Rep 7: 157-167, 2000.
35. Tan H, Zhong Y and Pan Z: Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines. BMC Cancer 9: 31, 2009.
36. Shi L, Dong B, Li Z, Lu Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Wang Z and Xie Y: Expression of ER-α36, a novel variant of estrogen receptor a, and resistance to tamoxifen treatment in breast cancer. J Clin Oncol 27: 3423-3429, 2010.